F. E. Romesberg et al.
(m, 1H, H-1’), 4.47 (dt, J=7.7, 5.6 Hz, 1H, H-3’), 4.11 (s, 2H, NH2),
4.05–3.84 (m, 2H, H-5’,H-5’’), 3.75–3.68 (m, 4H, OCH3, H-4’), 2.20 (ddd,
J=12.7, 7.3, 5.4 Hz, 1H, H-2’), 2.00 (m, 1H, H-2’’), 1.13–1.00 ppm (m,
28H, iPr); 13C NMR (125 MHz, CD3CN): d=158.3 (C2), 149.6 (C4), 128.0
(C6), 120.2 (C1), 107.1 (C5), 98.6 (C3), 86.3 (C4’), 74.3 (C1’), 74.0 (C3’), 64.2
(C5’), 55.8 (OCH3), 42.5 (C2’), 17.9–13.4 ppm (iPr); HRMS (ESI+) m/z:
calcd for C24H44NO5Si2 [M+H]+ 482.2752, found 482.2748.
compound 5c was obtained as white foam after evaporation of the sol-
vent (75 mg, 0.27 mmol, 51% yield). 1H NMR (600 MHz, CD3OD): d=
7.40 (d, J=8.3 Hz, 1H, H-6), 7.33 (d, J=1.8 Hz, 1H, H-3), 7.02 (dd, J=
8.3, 1.8 Hz, 1H, H-5), 5.38 (dd, J=10.2, 5.6 Hz, 1H, H-1’), 4.27 (m, 1H,
H-3’), 3.90 (td, J=5.2, 2.7 Hz, 1H, H-4’), 3.80 (s, 3H, OCH3), 3.65 (m,
2H, H-5’, H-5’’), 2.27 (ddd, J=13.1, 5.5, 1.7 Hz, 1H, H-2’), 2.10 (s, 3H,
COCH3), 1.80 ppm (ddd, J=13.2, 10.3, 6.0 Hz, 1H, H-2’’); 13C NMR
(150 MHz, CD3OD): d=171.5 (NHC=O), 157.8 (C2), 140.1 (C4), 127.2
(C6), 127.2 (C1), 112.7 (C5), 103.7 (C3), 88.5 (C4’), 76.2 (C1’), 74.4 (C3’),
64.0 (C5’), 55.7 (OCH3), 43.1 (C2’), 23.9 ppm (COCH3); HRMS (ESI+) m/
z: calcd for C14H20NO5 [M+H]+ 282.1341, found 290.1351.
Compound 5a: A solution of 70% aqueous tert-butyl hydroperoxide
(160 mL, 1.18 mmol, 3.8 equiv) was added dropwise over a period of
15 min to a solution of 4 (150 mg, 0.31 mmol, 1 equiv) and potassium
iodide (5.1 mg, 0.031 mmol, 0.1 equiv) in CH3CN (1.1 mL), and the mix-
ture was stirred at 758C in the dark for 2 h. The mixture was quenched
with saturated aqueous Na2S2O3, washed with brine, extracted with ethyl
acetate, dried (Na2SO4), filtered and evaporated. The resulting residue
was dissolved in tetrahydrofuran (1.5 mL), tetrabutylammonium fluoride
(1m; 0.5 mL, 0.5 mmol) in tetrahydrofuran was added, and the mixture
was stirred for 1 h at room temperature. The reaction mixture was diluted
with ethyl acetate, quenched with saturated aqueous NaHCO3, washed
with brine, dried (Na2SO4), filtered and evaporated. The residue was sub-
jected to silica gel column chromatography with a step gradient of metha-
nol (0–4%) in ethyl acetate. The desired compound 5a was obtained as
white foam after evaporation of the solvent (32 mg, 0.12 mmol, 38%).
1H NMR (500 MHz, CD3CN): d=7.82 (dd, J=8.4, 2.2 Hz, 1H, H-5),
7.77–7.69 (m, 2H, H-6, H-3), 5.32 (dd, J=10.1, 5.8 Hz, 1H, H-1’), 4.24
(dt, J=5.2, 2.1 Hz, 1H, H-3’), 3.91 (s, 3H, OCH3), 3.88 (td, J=5.0,
2.6 Hz, 1H, H-4’), 3.63–3.59 (dd, J=5.0, 0.9 Hz, 2H, H-5’, H-5’’), 2.32
(ddd, J=13.0, 5.7, 2.0 Hz, 1H), 1.68 ppm (ddd, J=13.1, 10.1, 5.9 Hz,
1H); 13C NMR (125 MHz, CD3CN): d=157.4 (C2), 149.0 (C4), 140.3 (C1),
127.1 (C6), 116.6 (C5), 106.1 (C3), 88.5 (C4’), 75.5 (C1’), 73.9 (C3’), 63.7
(C5’), 56.8 (OCH3), 42.9 ppm (C2’); HRMS (ESI+) m/z: calcd for
C12H16NO6 [M+H]+ 270.0972, found 270.0984.
Compound 5d: Triethylamine (170 mL, 1.24 mmol, 1.7 equiv) and then
trifluoroacetic anhydride (170 mL, 0.88 mmol, 1.2 equiv) were added
dropwise to a solution of 4 (350 mg, 0.73 mmol, 1 equiv) in CH2Cl2
(2 mL) at 108C. The reaction mixture was stirred at room temperature
for 20 min at 108C and then quenched with saturated aqueous NaHCO3.
The organic layer was diluted with CH2Cl2, washed with brine, dried
(Na2SO4), filtered and evaporated. The resulting residue was dissolved in
tetrahydrofuran (5 mL), tetrabutylammonium fluoride (1m; 1.9 mL,
1.9 mmol) in tetrahydrofuran was added and the mixture was stirred for
1 h at room temperature. The reaction mixture was diluted with ethyl
acetate, quenched with saturated aqueous NaHCO3, washed with brine,
dried (Na2SO4), filtered and evaporated. The residue was subjected to
silica gel column chromatography with a step gradient of methanol (0–
10%) in CH2Cl2. The desired compound 5c was obtained as white foam
after evaporation of the solvent (200 mg, 0.60 mmol, 81% yield).
1H NMR (600 MHz, CD3CN): d=9.25 (s, 1H, NH), 7.50 (d, J=8.2 Hz,
1H, H-6), 7.27 (d, J=1.9 Hz, 1H, H-3), 7.19 (m, 1H, H-5), 5.27 (dd, J=
10.2, 5.6 Hz, 1H, H-1’), 4.22 (m, 1H, H-3’), 3.82 (d, J=27.6 Hz, 4H, H-4’,
OCH3), 3.59 (d, J=4.9 Hz, 2H, H-5’, H-5’’), 2.22 (m, 1H, H-2’), 1.72 ppm
(m, 1H, H-2’’); 13C NMR (150 MHz, CD3CN): d=157.5 (C2), 156.2–155.4
(NHC=O), 136.9 (C4), 129.7 (C6), 127.3 (C1), 119.8–114.1 (CF3), 113.7
(C5), 104.7 (C3), 88.2 (C4’), 75.4 (C1’), 74.1 (C3’), 63.9 (C5’), 56.2 (OCH3),
43.1 ppm (C2’); HRMS (ESI+) m/z: calcd for C14H17F3NO5 [M+H]+
336.1053, found 336.1066.
Compound 5b: A solution of 4 (250 mg, 0.52 mmol, 1 equiv) and 2,5-di-
methoxytetrahydrofuran (170 mg, 1.3 mmol, 2.5 equiv) in H2O (0.8 mL)
was heated to 1408C for 30 min in a microwave synthesizer (Biotage AB,
Sweden). The reaction was allowed to cool and the resulting mixture was
diluted with ethyl acetate, quenched with saturated aqueous NaHCO3,
washed with brine, dried (Na2SO4), filtered and evaporated. The resulting
residue was dissolved in tetrahydrofuran (3 mL), tetrabutylammonium
fluoride (1m; 1 mL, 1 mmol) in tetrahydrofuran was added and the mix-
ture was stirred for 1 h at room temperature. The reaction mixture was
diluted with ethyl acetate, quenched with saturated aqueous NaHCO3,
washed with brine, dried (Na2SO4), filtered and evaporated. The residue
was subjected to silica gel column chromatography with a step gradient
of methanol (0–8%) in CH2Cl2. The desired compound 5b was obtained
as white foam after evaporation of the solvent (95 mg, 0.33 mmol, 63%).
1H NMR (600 MHz, CD3CN): d=7.52 (d, J=8.0 Hz, 1H, H-6), 7.17 (m,
J=2.1 Hz, 2H, H-7), 7.02 (m, 2H, H-5, H-3), 6.29 (t, J=2.2 Hz, 2H, H-
8), 5.30 (dd, J=10.2, 5.6 Hz, 1H, H-1’), 4.23 (m, 1H, H-3’), 3.88 (s, 2H,
OCH3), 3.83 (td, J=5.0, 2.6 Hz, 1H, H-4’), 3.60 (t, J=5.1 Hz, 2H), 3.21
(d, J=3.7 Hz, 1H, OH-3’), 2.92 (t, J=5.7 Hz, 1H, OH-5’), 2.22 (m, 1H,
H-2’), 1.76 ppm (ddd, J=13.0, 10.3, 6.0 Hz, 1H, H-2’’); 13C NMR
(150 MHz, CD3CN): d=158.1 (C2), 141.6 (C4), 129.1 (C6), 128.0 (C1),
120.2 (C7), 112.6 (C5), 111.1 (C8), 104.0 (C3), 88.2 (C4’), 75.4 (C1’), 74.1
(C3’), 63.8 (C5’), 56.4 (OCH3), 43.1 ppm (C2’); HRMS (ESI+) m/z: calcd
for C16H20NO4 [M+H]+ 290.1387, found 290.1397.
General procedure for triphosphate synthesis: Proton sponge (1.3 equiv)
and the free nucleoside derivative (1.0 equiv) were dissolved in dry tri-
methyl phosphate (40 equiv) and cooled to ꢀ158C under nitrogen atmos-
phere. Freshly distilled POCl3 (1.3 equiv) was added dropwise and the re-
sulting mixture was stirred at ꢀ108C for 2 h. Tributylamine (6.0 equiv)
and a solution of tributylammonium pyrophosphate (5.0 equiv) in dime-
thylformamide (0.5m) were added. Over 30 min, the reaction was allowed
to warm slowly to 08C and then was quenched by addition of 0.5m aque-
ous Et3NH2CO3 (TEAB) pH 7.5 (2 vol. equiv). The mixture was diluted
twofold with H2O and the product was isolated on a DEAE Sephadex
column (GE Healthcare) with an elution gradient of 0 to 1.2m TEAB,
evaporated, co-distilled with H2O (3ꢂ). Additional purification by re-
verse-phase (C18) HPLC (0–35% CH3CN in 0.1m TEAB, pH 7.5) was
performed.
Compound 6a: 31P NMR (162 MHz, D2O): d=ꢀ10.52 (d, J=19.8 Hz, g-
P), ꢀ10.84 (d, J=20.2 Hz, a-P), ꢀ22.92 ppm (t, J=20.1 Hz, b-P); MS
(MALDI-ToFꢀ, matrix: 9-aminoacridine) m/z: [MꢀH]ꢀ calcd for
C12H17NO15P3, 508.2; found, 508.3; e(l=330 nm) =2200mꢀ1 cmꢀ1; e(l=285 nm)
=
4800mꢀ1 cmꢀ1
.
Compound 6b: 31P NMR (162 MHz, D2O): d=ꢀ10.22 (d, J=19.8 Hz, g-
P), ꢀ10.75 (d, J=20.1 Hz, a-P), ꢀ22.82 ppm (t, J=20.0 Hz, b-P); MS
(MALDI-ToF, matrix: 9-aminoacridine) m/z: [MꢀH]ꢀ calcd for
Compound 5c: Triethylamine (125 mL, 0.89 mmol, 1.7 equiv) and then
acetic anhydride (60 mL, 0.62 mmol, 1.2 equiv) were added dropwise to a
solution of 4 (250 mg, 0.52 mmol, 1 equiv) in CH2Cl2 (600 mL). The reac-
tion mixture was stirred at room temperature for 20 min and then
quenched with saturated aqueous NaHCO3. The organic layer was dilut-
ed with CH2Cl2, washed with brine, dried (Na2SO4), filtered and evapo-
rated. The resulting residue was dissolved in tetrahydrofuran (2 mL),
C16H21NO13P3, 528.3; found 527.8; e(l=283 nm) =5080mꢀ1 cmꢀ1; e(l=256 nm)
=
10850mꢀ1 cmꢀ1
.
Compound 6c: 31P NMR (202 MHz, D2O): d=ꢀ6.35 (d, J=16.9 Hz, g-
P), ꢀ10.74 (d, J=19.7 Hz, a-P), ꢀ22.38 ppm (m, b-P); MS (MALDI-
ToFꢀ, matrix: 9-aminoacridine) m/z: [MꢀH]ꢀ calcd for C14H21NO14P3,
520.2; found 519.3; e(l=282 nm) =2700mꢀ1 cmꢀ1; e(l=248 nm) =7500mꢀ1 cmꢀ1
.
tetraACHTUNGTRENNUNGbutylACHTUNGTRENNUNGammonium fluoride (1m; 1 mL, 1 mmol) in tetrahydrofuran
Compound 6d: 31P NMR (162 MHz, D2O): d=ꢀ10.38 (d, J=19.8 Hz, g-
P), ꢀ10.87 (d, J=20.2 Hz, a-P), ꢀ22.82 ppm (t, J=20.0 Hz, b-P); MS
(MALDI-ToFꢀ, matrix: 9-aminoacridine) m/z: [MꢀH]ꢀ calcd for
was added and the mixture was stirred for 1 h at room temperature. The
reaction mixture was diluted with ethyl acetate, quenched with saturated
aqueous NaHCO3, washed with brine, dried (Na2SO4), filtered and
evaporated. The residue was subjected to silica gel column chromatogra-
phy with a step gradient of methanol (0–12%) in CH2Cl2. The desired
C14H18F3NO14P3, 574.2; found 573.9; e(l=285 nm) =3780mꢀ1 cmꢀ1; e(l=251 nm)
=
7450mꢀ1 cmꢀ1
.
1238
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2012, 18, 1231 – 1239